series-b
Stage
2021
Founded
1
Investors
About
Jaguar Gene Therapy is a clinical-stage biotechnology company focused on accelerating breakthroughs in gene therapy for patients suffering from severe genetic diseases, including those affecting sizable patient populations. The company is advancing a pipeline of gene therapies targeting diseases with significant unmet needs, such as genetic causes of autism spectrum disorder, Phelan-McDermid syndrome, Type 1 galactosemia, and Type 1 diabetes.
Explore Jaguar Gene Therapy's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.